Search

everythinglearnresearchcommunity

for

Search:↓

Medical castration in prostate cancer patients can increase the risk of serious heart rhythm problems, so it's important to monitor heart activity during treatment.

A woman's male-pattern facial hair growth was caused by a rare malignant ovarian tumor that was difficult to diagnose and treat.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

Most patients treated with low-dose alpha-interferon for malignant melanoma experienced skin side effects, with hair loss being the most frequent.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

Mouse skin cancer progression involves a unique group of cells marked by ABCG2 and MTS24.

Banana (Musa × paradisiaca) may help fight cervical cancer and skin cancer.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

A clinically suspected melanoma appeared benign under the microscope but was confirmed by specific tests and a rare mutation.

High levels of ODC and a mutant Ha-ras gene cause tumors in mice.

FDG PET/CT scans can change cancer treatment plans for dogs.

Indian Hedgehog helps control skin cell growth and protects against aggressive skin cancer.

Markers CRABP1, Nestin, and Ephrin B2 are present in skin cancer environments and may influence their development.

Hair structure worsens as tumors grow in mice.

Interleukin-2 treatment improved hair growth, sexual function, and reduced fungal infection in a patient with thymoma-related symptoms.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

The mTOR pathway may be involved in the development of hair follicle tumors, with higher activity in malignant tumors.

Malignant melanoma is the deadliest skin cancer, while BCC is the most common but rarely spreads, and SCC is more aggressive than BCC.

Vascular patterns in dermoscopy help tell apart malignant and benign skin tumors.

Some skin tumors from hair follicles and glands can be linked to genetic syndromes and may be benign or malignant.

Most skin tumors in the study were benign, with squamous cell carcinoma being the most common malignant type.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Benign skin adnexal tumors are more common than malignant ones, with trichoepithelioma and chondroid syringoma being the most frequent types.

Skin diseases differ between Ghana and the UK, with infections most common in Ghana and malignant skin diseases most prevalent in the UK.

The document concludes that rib-sparing techniques in breast reconstruction have limited benefits, sentinel lymph node biopsy is needed for desmoplastic melanoma, certain hair preservation methods improve graft survival, partial turbinectomy effectively reduces nasal obstruction, nipple shields with irrigation may reduce capsular contracture, and thicker malignant melanomas have a higher risk of non-skin cancers.

The document concludes that rib-sparing techniques in breast reconstruction have limited benefits, sentinel lymph node biopsy is needed for desmoplastic melanoma, certain hair preservation methods improve graft survival, partial turbinectomy effectively reduces nasal obstruction, nipple shields with irrigation may reduce capsular contracture, and thicker malignant melanomas have a higher risk of non-skin cancers.

The hair dye formulations tested did not cause long-term toxicity or cancer in mice.

The term "porokeratotic adnexal ostial nevus" is proposed to unify overlapping skin conditions involving eccrine and hair follicles.

The AI tool helped primary care doctors and nurse practitioners diagnose skin conditions more accurately.

Mice with human skin protein K8 had more skin problems and cancer.